Artigos de revistas sobre o tema "Prophylactic ICD-implantation"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Prophylactic ICD-implantation".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Pedersen, Susanne Bendesgaard, Dóra Körmendiné Farkas, Søren Pihlkjær Hjortshøj, Hans Erik Bøtker, Jens Brock Johansen, Berit Thornvig Philbert, Jens Haarbo, Reimar Wernich Thomsen e Jens Cosedis Nielsen. "Significant regional variation in use of implantable cardioverter-defibrillators in Denmark". European Heart Journal - Quality of Care and Clinical Outcomes 5, n.º 4 (20 de fevereiro de 2019): 352–60. http://dx.doi.org/10.1093/ehjqcco/qcz008.
Texto completo da fonteSacher, Frédéric, Vincent Probst, Dominique Babuty, Frederique Mizon-Gerard, Philippe Maury, Jacques Mansourati, Philippe Mabo et al. "Multicenter study of prophylactic ICD implantation in Brugada syndrome". Heart Rhythm 2, n.º 5 (maio de 2005): S40. http://dx.doi.org/10.1016/j.hrthm.2005.02.133.
Texto completo da fonteBoas, Rune, Nikolay Sappler, Lukas von Stülpnagel, Mathias Klemm, Ulrik Dixen, Jens Jakob Thune, Steen Pehrson et al. "Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy". Circulation 145, n.º 10 (8 de março de 2022): 754–64. http://dx.doi.org/10.1161/circulationaha.121.056464.
Texto completo da fonteZabel, Markus, Rik Willems, Andrzej Lubinski, Axel Bauer, Josep Brugada, David Conen, Panagiota Flevari et al. "Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study". European Heart Journal 41, n.º 36 (6 de maio de 2020): 3437–47. http://dx.doi.org/10.1093/eurheartj/ehaa226.
Texto completo da fontePAISEY, J. "P-494 The prevalence of criteria for prophylactic ICD implantation". Europace 4 (dezembro de 2003): B183. http://dx.doi.org/10.1016/s1099-5129(03)92242-2.
Texto completo da fontePaisey, J. R., Y. Yue, K. Elkins, T. Betts, P. R. Roberts e J. M. Morgan. "P-494 The prevalence of criteria for prophylactic ICD implantation". EP Europace 4, Supplement_2 (1 de dezembro de 2003): B183. http://dx.doi.org/10.1016/eupace/4.supplement_2.b183.
Texto completo da fonteSacher, F., J. Mansourati, D. Babuty, V. Probst, M. Salvador, S. Garrigue, P. Sanders, M. Haissaguerre, J. Clementy e H. Le Marec. "434 Multicenter study of prophylactic ICD implantation in Brugada syndrome". EP Europace 7, Supplement_1 (2005): 96–97. http://dx.doi.org/10.1016/eupace/7.supplement_1.96-b.
Texto completo da fonteMallavarapu, Vamshi, Bhargavi Degapudi, Monica Williams, Glenn Frazier, Arshneel Kochar, Alaa Shalaby, Francis E. Marchlinski et al. "Outcomes in veteran patients with ischemic cardiomyopathy undergoing prophylactic ICD implantation". Heart Rhythm 2, n.º 5 (maio de 2005): S282—S283. http://dx.doi.org/10.1016/j.hrthm.2005.02.889.
Texto completo da fonteZabel, Markus, Christian Sticherling, Rik Willems, Andrzej Lubinski, Axel Bauer, Leonard Bergau, Frieder Braunschweig et al. "Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation". ESC Heart Failure 6, n.º 1 (9 de outubro de 2018): 182–93. http://dx.doi.org/10.1002/ehf2.12367.
Texto completo da fonteLuermans, J. G. L. M., M. Mafi Rad e K. Vernooy. "A call for re-evaluation of the guidelines for prophylactic ICD implantation". Netherlands Heart Journal 22, n.º 10 (29 de agosto de 2014): 429–30. http://dx.doi.org/10.1007/s12471-014-0591-3.
Texto completo da fonteZakine, Cyril, Rodrigue Garcia, Kumar Narayanan, Estelle Gandjbakhch, Vincent Algalarrondo, Nicolas Lellouche, Marie-Cécile Perier et al. "Prophylactic implantable cardioverter-defibrillator in the very elderly". EP Europace 21, n.º 7 (19 de março de 2019): 1063–69. http://dx.doi.org/10.1093/europace/euz041.
Texto completo da fonteDimitriadis, Zisis, Frank van Buuren, Nikola Bogunovic, Dieter Horstkotte e Lothar Faber. "Marked Regression of Left Ventricular Hypertrophy after Outflow Desobliteration in HOCM". Case Reports in Medicine 2012 (2012): 1–2. http://dx.doi.org/10.1155/2012/546942.
Texto completo da fonteTimal, Rohit J., Veronique de Gucht, Joris I. Rotmans, Liselotte C. R. Hensen, Maurits S. Buiten, Mihaly K. de Bie, Hein Putter, Martin J. Schalij, Ton J. Rabelink e J. Wouter Jukema. "The impact of transvenous cardioverter-defibrillator implantation on quality of life, depression and optimism in dialysis patients: report on the secondary outcome of QOL in the randomized controlled ICD2 trial". Quality of Life Research 30, n.º 6 (19 de fevereiro de 2021): 1605–17. http://dx.doi.org/10.1007/s11136-020-02744-7.
Texto completo da fonteVamos, Mate, Laszlo Saghy e Gabor Bencsik. "Implantation of a VDD implantable cardioverter-defibrillator lead via a persistent left superior vena cava". Herzschrittmachertherapie + Elektrophysiologie 33, n.º 1 (6 de janeiro de 2022): 81–83. http://dx.doi.org/10.1007/s00399-021-00835-7.
Texto completo da fonteArgentiero, Adriana, Maria Cristina Carella, Donato Mandunzio, Giulia Greco, Saima Mushtaq, Andrea Baggiano, Fabio Fazzari et al. "Cardiac Magnetic Resonance as Risk Stratification Tool in Non-Ischemic Dilated Cardiomyopathy Referred for Implantable Cardioverter Defibrillator Therapy—State of Art and Perspectives". Journal of Clinical Medicine 12, n.º 24 (18 de dezembro de 2023): 7752. http://dx.doi.org/10.3390/jcm12247752.
Texto completo da fonteNodera, Minoru, Hitoshi Suzuki, Yoshiyuki Matsumoto, Masashi Kamioka, Takashi Kaneshiro, Akiomi Yoshihisa , Tetsuya Ohira e Yasuchika Takeishi. "Association between Serum Uric Acid Level and Ventricular Tachyarrhythmia in Heart Failure Patients with Implantable Cardioverter-Defibrillator". Cardiology 140, n.º 1 (2018): 47–51. http://dx.doi.org/10.1159/000488851.
Texto completo da fonteWichterle, Dan. "Risk Stratification in Post-myocardial Infarction Patients". European Cardiology Review 6, n.º 3 (2010): 22. http://dx.doi.org/10.15420/ecr.2010.6.3.22.
Texto completo da fonteSCHAER, B. "P-177 Is a prophylactic icd implantation in patients with DCM useful or not?" Europace 4 (dezembro de 2003): B108. http://dx.doi.org/10.1016/s1099-5129(03)91929-5.
Texto completo da fonteSchaer, B., M. Zellweger, T. Cron e S. Osswald. "P-177 Is a prophylactic icd implantation in patients with DCM useful or not?" EP Europace 4, Supplement_2 (1 de dezembro de 2003): B108. http://dx.doi.org/10.1016/eupace/4.supplement_2.b108-b.
Texto completo da fonteFischer-Rasokat, Ulrich, Matthias Renker, Christoph Liebetrau, Maren Weferling, Andreas Rolf, Andreas Hain, Johannes Sperzel, Yeong-Hoon Choi, Christian W. Hamm e Won-Keun Kim. "Long-Term Survival in Patients with or without Implantable Cardioverter Defibrillator after Transcatheter Aortic Valve Implantation". Journal of Clinical Medicine 10, n.º 13 (30 de junho de 2021): 2929. http://dx.doi.org/10.3390/jcm10132929.
Texto completo da fonteZabel, Markus, Simon Schlögl, Andrzej Lubinski, Jesper Hastrup Svendsen, Axel Bauer, Elena Arbelo, Sandro Brusich et al. "Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project". Journal of Electrocardiology 57 (novembro de 2019): S34—S39. http://dx.doi.org/10.1016/j.jelectrocard.2019.09.001.
Texto completo da fonteNaegele, H., M. A. Castel, G. Groth, F. M. Wagner e H. H. Reichenspurner. "Sudden death in patients evaluated for heart transplantation: HFSS detects possible candidates for prophylactic ICD implantation". Journal of Heart and Lung Transplantation 23, n.º 2 (fevereiro de 2004): S57. http://dx.doi.org/10.1016/j.healun.2003.11.046.
Texto completo da fonteHaanschoten, Danielle, e Arif Elvan. "The DAPA Trial in the Context of Previous Prophylactic ICD Landmark Trials". Arrhythmia & Electrophysiology Review 10, n.º 3 (27 de outubro de 2021): 154–58. http://dx.doi.org/10.15420/aer.2021.23.
Texto completo da fonteVersteeg, Henneke, Ivy Timmermans, Jos Widdershoven, Geert-Jan Kimman, Sébastien Prevot, Thomas Rauwolf, Marcoen F. Scholten et al. "Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial". EP Europace 21, n.º 9 (5 de junho de 2019): 1360–68. http://dx.doi.org/10.1093/europace/euz140.
Texto completo da fonteFrydensberg, Vivi Skibdal, Jens Brock Johansen, Sören Möller, Sam Riahi, Sonja Wehberg, Jens Haarbo, Berit Thornvig Philbert et al. "Anxiety and depression symptoms in Danish patients with an implantable cardioverter-defibrillator: prevalence and association with indication and sex up to 2 years of follow-up (data from the national DEFIB-WOMEN study)". EP Europace 22, n.º 12 (27 de outubro de 2020): 1830–40. http://dx.doi.org/10.1093/europace/euaa176.
Texto completo da fonteOebel, SR, S. Hilbert, L. Ueberham, J. Kosiuk, S. Richter, M. Doering, A. Bollmann et al. "P1747Risk stratification by CMR imaging for patients undergoing primary prophylactic ICD implantation - Differences between ischemic and non- ischemic etiology". EP Europace 19, suppl_3 (junho de 2017): iii382. http://dx.doi.org/10.1093/ehjci/eux161.057.
Texto completo da fonteKleemann, T., M. Strauss, K. Kouraki, N. Werner e R. Zahn. "P463Risk assessment for primary prophylactic ICD implantation in hypertrophic cardiomyopathy using the risk calculator: discrepancy between theory and clinical practice?" EP Europace 20, suppl_1 (1 de março de 2018): i92—i93. http://dx.doi.org/10.1093/europace/euy015.272.
Texto completo da fonteWaezsada, Elias, Julie Hutter, Patrick Kahle, Joerg Yogarajah, Johannes Sperzel, Malte Kuniss, Thomas Neumann, Horst Esser, Christian Hamm e Andreas Hain. "Guideline Directed Medical Therapy at Discharge and Further Uptitration Leading to Reduction in Indication for Prophylactic ICD Implantation during Protected Waiting Period". Journal of Clinical Medicine 11, n.º 20 (18 de outubro de 2022): 6122. http://dx.doi.org/10.3390/jcm11206122.
Texto completo da fonteSilka, Michael J., e Yaniv Bar-Cohen. "Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?" Circulation: Arrhythmia and Electrophysiology 1, n.º 4 (outubro de 2008): 298–306. http://dx.doi.org/10.1161/circep.108.801522.
Texto completo da fonteTriedman, John K. "Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?" Circulation: Arrhythmia and Electrophysiology 1, n.º 4 (outubro de 2008): 307–16. http://dx.doi.org/10.1161/circep.108.805903.
Texto completo da fontevon Stülpnagel, Lukas, Bernhard Wolf e Axel Bauer. "Biosignal-guided personalized therapy". Current Directions in Biomedical Engineering 3, n.º 2 (7 de setembro de 2017): 179–81. http://dx.doi.org/10.1515/cdbme-2017-0037.
Texto completo da fonteOebel, SR, S. Hilbert, L. Ueberham, J. Kosiuk, S. Richter, M. Doering, A. Bollmann et al. "P1746Risk stratification for patients undergoing primary prophylactic ICD implantation- the role of CMR imaging for predicting new onset ventricular arrhythmias and death". EP Europace 19, suppl_3 (junho de 2017): iii381—iii382. http://dx.doi.org/10.1093/ehjci/eux161.056.
Texto completo da fonteFaber, Lothar. "Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care". Advances in Medicine 2014 (2014): 1–14. http://dx.doi.org/10.1155/2014/464851.
Texto completo da fonteForleo, Giovanni B., Francesco Solimene, Ennio C. Pisanò, Gabriele Zanotto, Valeria Calvi, Carlo Pignalberi, Giampiero Maglia et al. "Long‐term outcomes after prophylactic ICD and CRT‐D implantation in nonischemic patients: Analysis from a nationwide database of daily remote‐monitoring transmissions". Journal of Cardiovascular Electrophysiology 30, n.º 9 (18 de junho de 2019): 1626–35. http://dx.doi.org/10.1111/jce.14006.
Texto completo da fonteSantangeli, Pasquale, Luigi Di Biase, Eloisa Basile, Amin Al-Ahmad e Andrea Natale. "Outcomes in Women Undergoing Electrophysiological Procedures". Arrhythmia & Electrophysiology Review 2, n.º 1 (2013): 41. http://dx.doi.org/10.15420/aer.2013.2.1.41.
Texto completo da fonteBriasoulis, Alexandros, Christos Kourek, Adamantia Papamichail, Konstantinos Loritis, Dimitrios Bampatsias, Evangelos Repasos, Andrew Xanthopoulos, Elias Tsougos e Ioannis Paraskevaidis. "Arrhythmias in Patients with Cardiac Amyloidosis: A Comprehensive Review on Clinical Management and Devices". Journal of Cardiovascular Development and Disease 10, n.º 8 (5 de agosto de 2023): 337. http://dx.doi.org/10.3390/jcdd10080337.
Texto completo da fonteKlein, Helmut U., Michael Block, Heinz Voeller, Wolfram Kamke, Thomas Fetsch, Andreas Suciu e Klaus Contzen. "Prophylactic ICD-implantation in real life 2 years after MADIT II unmasked by the prevention of sudden cardiac death II - registry: Only few patients receive ICDs". Heart Rhythm 2, n.º 5 (maio de 2005): S243—S244. http://dx.doi.org/10.1016/j.hrthm.2005.02.762.
Texto completo da fonteHeidbuchel, Hein, Rik Willems, Luc Jordaens, Brian Olshansky, Francois Carre, Ignacio F. Lozano, Matthias Wilhelm et al. "Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort". European Journal of Preventive Cardiology 26, n.º 7 (27 de fevereiro de 2019): 764–75. http://dx.doi.org/10.1177/2047487319834852.
Texto completo da fonteLewenhardt, Marie, Fabienne Kreimer, Assem Aweimer, Andreas Pflaumbaum, Andreas Mügge e Michael Gotzmann. "Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients". Clinical Cardiology, 14 de novembro de 2023. http://dx.doi.org/10.1002/clc.24191.
Texto completo da fonteSams, L. E., M. Klemm, M. Woerndl, L. Bachinger, L. E. Villegas Sierra, S. Massberg e K. D. Rizas. "Periodic Repolarization Dynamics (PRD) identifies patients who profit from ICD implantation, A meta-analysis of the predictive value of PRD". European Heart Journal 44, Supplement_2 (novembro de 2023). http://dx.doi.org/10.1093/eurheartj/ehad655.681.
Texto completo da fonteMigliore, Federico, Nicolò Martini, Leonardo Calo', Annamaria Martino, Giulia Winnicki, Riccardo Vio, Chiara Condello et al. "Predictors of late arrhythmic events after generator replacement in Brugada syndrome treated with prophylactic ICD". Frontiers in Cardiovascular Medicine 9 (22 de julho de 2022). http://dx.doi.org/10.3389/fcvm.2022.964694.
Texto completo da fonteKleemann, T., K. Kouraki, M. Strauss, O. Mohammad, A. Wenz e R. Zahn. "Incidence of ventricular tachyarrhythmias and clinical outcomes in primary prophylactic ICD patients in relation to localization of myocardial infarction". Europace 25, Supplement_1 (24 de maio de 2023). http://dx.doi.org/10.1093/europace/euad122.308.
Texto completo da fonteKristen, Arnt V., Thomas J. Dengler, Ute Hegenbart, Stefan O. Schonland, Falk-Udo Sack, Frederick Voss, Rüdiger Becker, Hugo A. Katus e Alexander Bauer. "Abstract 1657: Prophylactic Implantation Of Cardioverter Defibrillators In Patients With Severe Cardiac Amyloidosis". Circulation 116, suppl_16 (16 de outubro de 2007). http://dx.doi.org/10.1161/circ.116.suppl_16.ii_347-c.
Texto completo da fonteYang, P. S., Y. Kang, J. H. Sung, H. D. Park e B. Joung. "Survival among ischemic and non-ischemic heart failure patients with primary implantable cardioverter defibrillator therapy in Korea: a nationwide cohort study". European Heart Journal 42, Supplement_1 (1 de outubro de 2021). http://dx.doi.org/10.1093/eurheartj/ehab724.0698.
Texto completo da fonteKawahara, Yusei, Hisanori Kanazawa, Seiji Takashio, Yuichiro Tsuruta, Hitoshi Sumi, Takuya Kiyama, Shozo Kaneko et al. "Clinical, electrocardiographic, and echocardiographic parameters associated with the development of pacing and implantable cardioverter-defibrillator indication in patients with transthyretin amyloid cardiomyopathy". Europace, 26 de abril de 2023. http://dx.doi.org/10.1093/europace/euad105.
Texto completo da fonte"434 Multicenter study of prophylactic ICD implantation in Brugada syndrome". Europace 7 (junho de 2005): 96–97. http://dx.doi.org/10.1016/s1099-5129(05)80286-7.
Texto completo da fonteAlhakak, A., L. Ostergaard, J. H. Butt, M. Vinther, B. T. Philbert, P. K. Jacobsen, J. K. Petersen et al. "Mortality after implantable cardioverter defibrillators in dialysis patients: a nationwide study". European Heart Journal 41, Supplement_2 (1 de novembro de 2020). http://dx.doi.org/10.1093/ehjci/ehaa946.0791.
Texto completo da fonteGama, F., M. S. Carvalho, G. Rodrigues, F. M. Costa, D. Matos, J. Carmo, F. Mendes et al. "Idiopathic HFrEF. Is there room left for defibrillators?" European Heart Journal 41, Supplement_2 (1 de novembro de 2020). http://dx.doi.org/10.1093/ehjci/ehaa946.0727.
Texto completo da fonteZheng, C., A. H. Christensen, C. Joens, N. Risum, H. S. Bosselmann, B. T. Philbert, R. Frosted e H. Bundgaard. "Marked differences in ICD therapy frequencies between phenotypes". European Heart Journal 44, Supplement_2 (novembro de 2023). http://dx.doi.org/10.1093/eurheartj/ehad655.685.
Texto completo da fontePelli, Ari, M. Juhani Junttila, Tuomas V. Kenttä, Simon Schlögl, Markus Zabel, Marek Malik, Tobias Reichlin et al. "Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study". EP Europace, 29 de novembro de 2021. http://dx.doi.org/10.1093/europace/euab260.
Texto completo da fonte